Drugmakers Delay EU Launches Over Trump Pricing Fears
March 31, 2026·about 2 hours ago·via Reuters

Drugmakers hold back some European product launches, spooked by President Trump's aggressive push for Most Favored Nation pricing that forces them to match low foreign prices for Americans. Trump's America First strategy via TrumpRx.gov already slashes costs on blockbuster drugs like Ozempic from $1,000 to $350 monthly, with 16 firms signing deals for Medicaid and cash buyers. Read more about this...